comparemela.com
Home
Live Updates
Acasti Announces Poster Detailing its GTX-104 STRIVE-ON Trial : comparemela.com
Acasti Announces Poster Detailing its GTX-104 STRIVE-ON Trial
PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company ad...
Related Keywords
United States
,
Phoenix
,
Arizona
,
Canada
,
Canadian
,
Prashant Kohli
,
Mike Moyer
,
Exchange Commission
,
Securities Exchange
,
International Stroke Conference
,
Nasdaq
,
Acasti Pharma Inc
,
Stroke Conference
,
Intravenous Versus Enteral Nimodipine
,
Aneurysmal Subarachnoid Hemorrhage
,
Thursday February
,
Ongoing Clinical Trials
,
Subarachnoid Hemorrhage
,
Intensive Care Unit
,
Orphan Drug Designation
,
Securities Litigation Reform Act
,
Securities Act
,
Securities Exchange Act
,
comparemela.com © 2020. All Rights Reserved.